The conventional aetiological model of obesity and diabetes proposes a genetic predisposition and a precipitation by an unhealthy adult lifestyle. This hypothesis was challenged by David Barker who proposed that the intrauterine environment influences the risk of non-communicable diseases (NCDs). The original idea was based on fetal undernutrition because lower birth weight was associated with a higher risk of diabetes and heart disease. However, soon it was clear that the association was U shaped, and that the increased risk in large babies was driven by maternal obesity and diabetes. A number of human and animal studies have refined our ideas of ‘fetal programming', which is now thought to be related to acquired chemical changes in DNA (methylation), histones (acetylation and other) and the role of non-coding miRNAs. Maternal nutritional disturbances are the major programming stimulus, in addition to a deranged metabolism, infections, maternal stress, extreme atmospheric temperature, etc. The first demonstration of a link between fetal ‘starvation' and future ill-health was in the Dutch Hunger Winter studies. In the prospective Pune Maternal Nutrition Study, we found that small and thin Indian babies were more adipose compared to larger English babies, and their higher risk of future diabetes was reflected in higher insulin and leptin and lower adiponectin concentrations in the cord blood. This phenotype was partly related to a deranged 1-carbon metabolism due to an imbalance in vitamin B12 (low) and folate (high) nutrition, which was also related to insulin resistance in the offspring. Maternal obesity and diabetes have made an increasing contribution to childhood obesity and diabetes at a young age. This was prominently shown in Pima Indians but is now obvious in all other populations. The best window of opportunity to prevent fetal programming of NCDs is in the periconceptional period. This is the period when gametogenesis, fertilisation, implantation, embryogenesis and placentation occur. Improving the nutrition and the health of young girls could make a substantial contribution to reducing the rapidly rising epidemic of NCDs in the world. This is referred to as ‘primordial' prevention.

1.
Hu FB: Globalization of diabetes - the role of diet, lifestyle, and genes. Diabetes Care 2011;34:1249-1257.
2.
Barker DJ: In utero programming of chronic disease. Clin Sci (Lond) 1998;95:115-128.
3.
Ravelli GP, Stein ZA, Susser MW: Obesity in young men after famine exposure in utero and early infancy. N Engl J Med 1976;295:349-353.
4.
Freinkel N: Banting Lecture 1980. Of pregnancy and progeny. Diabetes 1980;29:1023-1035.
5.
Hales CN, Barker DJP: Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992; 35: 595-601.
6.
Hales CN, Barker DJ: The thrifty phenotype hypothesis. Br Med Bull 2001;60:5-20.
7.
Waddington CH: Embryology, epigenetics and biogenetics. Nature 1956;77:1241.
8.
Morgan HD, Santos F, Green K, Dean W, Reik W: Epigenetic reprogramming in mammals. Hum Mol Genet 2005;14:R47-R58.
9.
Regine PM, Theunissen S, Twigt J, Pestinger V, Sinclair KD: The periconceptional period, reproduction and long-term health of offspring: the importance of one-carbon metabolism. Hum Reprod Update 2013;19:640-655.
10.
Barker DJP: Mothers, Babies and Health in Later Life, ed 2. Edinburgh, Churchill Livingstone, 1998.
11.
Yajnik CS, Yudkin JS: The Y-Y paradox. Lancet 2004;363:163.
12.
Roseboom T, de Rooij S, Painter R: The Dutch famine and its long-term consequences for adult health. Early Hum Dev 2006;82:485-491.
13.
Schulz L: The Dutch Hunger Winter and the developmental origins of health and disease. Proc Natl Acad Sci USA 2010;107:16757-16758.
14.
Harding J: The nutritional basis of the fetal origins of adult disease. Int J Epidemiol 2001;30:15-23.
15.
Curhan GC, Chertow GM, Willet WC, Spiegelman D, Colditz GA, Mansson JE, Speizer FE, Stampfer MJ: Birth weight and adult hypertension and obesity in women. Circulation 1996;94:1310-1315.
16.
Whincup PH, Kaye SJ, Owen CG, et al: Birth weight and risk of type 2 diabetes: a systematic review. JAMA 2008;300:2886-2897.
17.
Yajnik CS: Diabetes in tropical developing countries; in Alberti KG, Krall LP (eds): The Diabetes Annual, ed 5. Amsterdam, Elsevier, 1990, pp 72-87.
18.
Yajnik CS: Diabetes in tropical developing countries; in Alberti KG, Krall LP (eds): The Diabetes Annual, ed 6. Amsterdam, Elsevier, 1991, pp 62-81.
19.
Yajnik CS, Fall CHD, Vaidya U, Pandit AN, Bavdekar A, Bhat DS, Osmond C, Hales CN, Barker DJ: Fetal growth and glucose and insulin metabolism in four-year-old Indian children. Diabet Med 1995;12:330-336.
20.
Bavdekar A, Yajnik CS, Fall CH, Bapat S, Pandit AN, Deshpande V, Bhave S, Kellingray SD, Joglekar C: Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes 1999;48:2422-2429.
21.
Yajnik CS, Fall CHD, Coyaji KJ, Hirve SS, Rao S, Barker DJP, Joglekar C, Kellingray S: Neonatal anthropometry: the thin-fat Indian baby. The Pune Maternal Nutrition Study. Int J Obes Relat Metab Disord 2003;26:173-180.
22.
Deshmukh US, Lubree HG, Yajnik CS: Intrauterine programming of non-communicable disease: role of maternal micronutrients. Sight Life Mag 2011; 25 :16-22.
23.
Modi N, Thomas EL, Uthaya SN, Umranikar S, Bell JD, Yajnik CS: Whole body magnetic resonance imaging of healthy newborn infants demonstrates increased central adiposity in Asian Indians. Pediatr Res 2009;65:584-587.
24.
Rao S, Yajnik CS, Kanade A, Fall CH, Margetts BM, Jackson AA, Shier R, Joshi S, Rege S, Lubree H, Desai B: Intake of micronutrient-rich foods in rural Indian mothers is associated with the size of their babies at birth: Pune Maternal Nutrition Study. J Nutr 2001;131:1217-1224.
25.
Yajnik CS, Deshpande SS, Panchanadikar AV, Naik SS, Deshpande JA, Coyaji KJ, Fall C, Refsum H: Maternal total homocysteine concentration and neonatal size in India. Asia Pac J Clin Nutr 2005;14:179-181.
26.
Yajnik CS, Deshpande SS, Jackson AA, Refsum H, Rao S, Fisher DJ, Bhat DS, Naik SS, Coyaji KJ, Joglekar CV, Joshi N, Lubree HG, Deshpande VU, Rege SS, Fall CH: Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia 2008;51:29-38.
27.
Muthayya S, Kurpad AV, Duggan CP, Bosch RJ, Dwarkanath P, Mhaskar A, Mhaskar R, Thomas A, Vaz M, Bhat S, Fawzi WW: Low maternal vitamin B12 status is associated with intrauterine growth retardation in urban South Indians. Eur J Clin Nutr 2006;60:791-801.
28.
Stewart CP, Christian P, Schulze KJ, Arguello M, LeClerq SC, Khatry SK, West KP Jr: Low maternal vitamin B12 status is associated with offspring insulin resistance regardless of antenatal micronutrient supplementation in rural Nepal. J Nutr 2011;141:1912-1917.
29.
Krishnaveni GV, Hill JC, Veena SR, Bhat DS, Wills AK, Karat CL, Yajnik CS, Fall CH: Low plasma vitamin B12 in pregnancy is associated with gestational ‘diabesity' and later diabetes. Diabetologia 2009;52:2350-2358.
30.
Kalhan SC: One-carbon metabolism, fetal growth and long-term consequences; in Bhatia J, Bhutta ZA, Kalhan SC (eds): Maternal and Child Nutrition: The First 1,000 Days. Nestlé Nutr Inst Workshop Ser. Basel, Karger, 2013, vol 74, pp 127-138.
31.
Rush EC, Katre P, Yajnik CS: Vitamin B12: one carbon metabolism, fetal growth and programming for chronic disease. Eur J Clin Nutr 2014;68:2-7.
32.
Deshmukh U, Katre P, Yajnik CS: Influence of maternal vitamin B12 and folate on growth and insulin resistance in the offspring; in Bhatia J, Bhutta ZA, Kalhan SC (eds): Maternal and Child Nutrition: The First 1,000 Days. Nestlé Nutr Inst Workshop Ser. Basel, Karger, 2013, vol 74, pp 145-156.
33.
Pedersen J: Diabetes mellitus and pregnancy: present status of the hyperglycaemia-hyperinsulinism theory and the weight of the newborn baby. Postgrad Med J 1971;suppl:66-67.
34.
Pettitt DJ, Baird HR, Aleck KA, Bennett PH, Knowler WC: Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy. NEJM 1983; 308 : 242-245.
35.
Pettitt DJ, Nelson RG, Saad MF, Bennett PH, Knowler WC: Diabetes and obesity in the offspring of Pima Indian women with diabetes during pregnancy. Diabetes Care 1993;16:310-314.
36.
Dabelea D, Hanson RL, Lindsay RS, Pettitt DJ, Imperatore G, Gabir MM, Roumain J, Bennett PH, Knowler WC: Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 2000;49:2208-2211.
37.
Dabelea D, Pettitt DJ: Intrauterine diabetic environment confers risks for type 2 diabetes mellitus and obesity in the offspring, in addition to genetic susceptibility. J Pediatr Endocrinol Metab 2001;14:1085-1091.
38.
Krishnaveni GV, Veena SR, Hill JC, Fall CHD: Intrauterine exposure to maternal diabetes is associated with higher adiposity and insulin resistance and clustering of cardiovascular risk markers in Indian children. Diabetes Care 2010;33:402-404.
39.
Clausen TD, Mathiesen ER, Hansen T, Pedersen O, Jensen DM, Lauenborg J, Damm P: High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care 2008;31:340-346.
40.
Silverman BL, Rizzo TA, Cho NH, Metzger BE: Long-term effects of the intrauterine environment. Diabetes Care 1998;21(suppl 2): B142-B149.
41.
Yajnik CS: Fetal programming of diabetes: still so much to learn! Diabetes Care 2010;33:1146-1148.
42.
Yajnik CS: Nutrient-mediated teratogenesis and fuel-mediated teratogenesis: two pathways of intrauterine programming of diabetes. Int J Gynaecol Obstet 2009;104(suppl 1):S27-S31.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.